AbbVie Inc (LTS:0QCV)
$ 252.5 -7.5 (-2.88%) Market Cap: 439.62 Bil Enterprise Value: 503.92 Bil PE Ratio: 70.28 PB Ratio: 0 GF Score: 80/100

AbbVie Inc. at Wells Fargo Healthcare Conference Transcript

Sep 09, 2026 / 02:15PM GMT
Mohit Bansal
Wells Fargo Securities LLC - Analyst

Thank you very much for joining us today. My name is Mohit Bansal. I am one of the biotech and pharma analysts here at Wells Fargo, and I am joined by AbbVie management team with us today. So from my left to right, we have Roopal Thakkar. He is the EVP and Head of Research, and Chief Scientific Officer at AbbVie. We have Jeff Stewart. He is the EVP and Chief Commercial Officer at AbbVie. And Scott Reents, he is the CFO of the company. Thank you very much, Team AbbVie, for joining us today.

Jeff Stewart
AbbVie Inc. - EVP and Chief Commercial Officer

Thanks for having us.

Questions & Answers

Mohit Bansal
Wells Fargo Securities LLC - Analyst

Thank you. So exciting times at AbbVie. I do not know. I have leaders from three different sections of AbbVie, so I will probably have 10,000 questions in 35 minutes. So maybe I will start with you, Jeff, right? I am sure there are a lot of questions around immunology. You have done a tremendous job with SKYRIZI and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot